We selected the 8E, p21 and SMT proteins for advancement based upon highly significant discrimination of VL patients from control and levels of protection in the infection model. α-tubulin was excluded at this juncture due to its high level of identity with human sequences.
← all excerpts
Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis.
1
—
—